A vaccine designed to target two different forms of Covid has been approved by the UK regulator for use as booster jabs in people over the age of 18.
Manufactured by the US firm Moderna, the vaccine targets not only the original coronavirus – as is the case for vaccines currently in use – but is designed specifically to target the Omicron variant BA.1, which fuelled a wave of Covid in the UK last winter.
